Company: NIVFW
Filing Date: 2025-08-21
Form Type: DRS
Source: 0001213900-25-079301
Chunk: 127

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-21
Form: DRS
Chunk 127
---
 however, require additional cash due to changing business conditions or other future developments,
including any investments or acquisitions it may decide to pursue. If its existing cash is insufficient to meet its requirements, NewGenIvf
may seek to issue debt or equity securities or obtain additional credit facilities. Financing may be unavailable in the amounts NewGenIvf
needs or on terms acceptable to it, if at all. Issuance of additional equity securities, including convertible debt securities, would
dilute NewGenIvf’s earnings per share. The incurrence of debt would divert cash for working capital and capital expenditures to
service debt obligations and could result in operating and financial covenants that restrict NewGenIvf’s operations and its ability
to pay dividends to its shareholders. If NewGenIvf is unable to obtain additional equity or debt financing as required, its business operations
and prospects may suffer. Please see “Risk Factors — Risks Relating to NewGenIvf’s Business and Industry — NewGenIvf requires a significant amount of capital to fund its operations and growth. If NewGenIvf cannot obtain sufficient capital on acceptable terms, its business, financial condition, and prospects may be materially and adversely affected.”

The following table presents
NewGenIvf’s selected consolidated cash flow data for the periods indicated.

|                                                                     |     | For the Year ended 
 December 31,       
 2024               |            |   |     | 2023 |            |   |
|:--------------------------------------------------------------------|:----|:-------------------|-----------:|:--|:----|:-----|-----------:|:--|
|                                                                     |     | US$                |            |   |     |      |            |   |
| Net cash used in operating activities                               |     |                    | (8,264,074 | ) |     |      | (1,766,135 | ) |
| Net cash used in investing activities                               |     |                    |    (53,045 | ) |     |      |    (69,848 | ) |
| Net cash provided by financing activities                           |     |                    |  8,675,790 |   |     |      |  1,881,493 |   |
| Net increase in cash and cash equivalents                           |     |                    |    358,671 |   |     |      |     45,510 |   |
| Effect of foreign currency translation on cash and cash equivalents |     |                    |     44,965 |